29th Edition

Litt's Drug Eruption & Reaction Manual

Edited By Neil H. Shear Copyright 2023
    536 Pages 3 B/W Illustrations
    by CRC Press

    536 Pages 3 B/W Illustrations
    by CRC Press

    Continue Shopping

    Litt’s Drug Eruption & Reaction Manual is intended as a succinct reference to give clinicians the essential information for an informed decision about patient management. The full database from which it is derived — Litt’s Drug Eruption & Reaction database: www.drugeruptiondata.com — currently holds over 1800 drug profiles with over 72,000 documented drug reactions, as evidenced by well over 153,000 references on PubMed and is internationally relied upon by medical practitioners for its unparalleled focus on adverse effects and cutaneous reactions. This 29th edition of the manual has been comprehensively updated for 2023 to give a quick precis of the essential information a clinician needs for an informed decision.

    This edition:
    ✓ Provides documentation of adverse reactions to the 1500 most consulted drug and herbal profiles
    ✓ Gives clinicians managing patients with many different medications a route to making an informed decision about problematic reactions
    ✓ Offers clinicians a one-stop reference for the essential information about a drug
    ✓ We allow you to search the profiles of thousands of generic and trade name drugs, while also providing over 60,000 references that link directly to PubMed, enabling you to better diagnose and treat your patients

    ✓ A to Z listing of the 1500 most consulted drug and herbal profiles (including supplements, vaccines, and botanicals), including generic name and trade names; pharmaceutical company; indications; half-life; and pregnancy category
    ✓ Descriptions of important reactions
    ✓ List of drugs that cause severe adverse reactions
    ✓ List of main classes of drugs
    ✓ 28 tables showing reactions of members of a class of drugs (such as statins or monoclonal antibodies), enabling clinicians to see at a glance whether a reaction is common to all drugs included in that class, or to a majority of them, or is known in only a handful—information that is critical for an informed decision to change drugs within the same class
    ✓ 2 tables showing reported genetic associations with cutaneous adverse drug reactions and recommendations regarding genetic screening to prevent cutaneous adverse drug reactions
    ✓ A concordance of synonyms and trade names for ease of cross-reference

    Introductory notes

    Drug profiles: generic names A–Z

    Descriptions of important reactions

    Drugs that cause important reactions

    Main classes of drugs

    Class reactions

    Genetic tables

    Concordance of synonyms and trade names with generic names


    Neil H. Shear, MD, FRCPC, FACP is Professor of Dermatology and Clinical Pharmacology and Toxicology, University of Toronto, Canada.